Search Results
Search results for "Heptares Therapeutics"
Results found for "Heptares Therapeutics"
- GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026
Endocrine Metabolic GPCRs 2026 and Biophysical Society Meeting previews; positive ACCESS data for Structure Therapeutics
- Precise druggability of the PTH type 1 receptor
PTHR signaling that could be extended to GPCRs to expedite discoveries of small molecules as novel therapeutic
- GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response to...
and stabilizing IGF1R, and suggests that it may serve as a valuable prognostic factor and potential therapeutic
- High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and...
particularly aggressive and heterogeneous disease with few effective targeted therapies and precision therapeutic
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
20th World Congress of Basic and Clinical Pharmacology GPCR Jobs Scientist I Cell Biology - Tectonic Therapeutic
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
puzzles and underscores the importance of understanding cellular processes at the molecular level for therapeutic
- G protein-coupled receptors that influence lifespan of human and animal models
substantial participation in a wide variety of processes of human pathophysiology and are one of the main therapeutic
- Crinetics Pharmaceuticals announced the formation of an independently operated new company...
stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics
- Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19...
Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19 and Other Antibody Therapeutics
- Your GPCR Program Decisions Depend on Good Data Interpretation
drug discovery; new strategies for inflammatory disease treatment; growth strategies from Tectonic Therapeutics
- HDX-MS-optimized approach to characterize nanobodies as tools for biochemical and structural ...
Overall, our work reveals insight into PI3KÎł regulation and identifies sites that may be exploited for therapeutic
- TLR4 biased small molecule modulators
Biased pharmacological modulators provide potential therapeutic benefits, including greater pharmacodynamic
- The development of modulators for lysophosphatidic acid receptors: A comprehensive review
the current status of ligand development targeting LPA receptors to modulate LPA signaling and their therapeutic
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
Antibodies, Bias, and the Expanding Modality Landscape Antibody therapeutics are now entering spaces
- Understanding Enzyme Inhibition In GPCR Discovery Programs
When “inhibition” becomes activation—and how that insight fuels next-gen therapeutic design.
- Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling
implications for drug development, as targeting these non-cognate interactions could lead to novel therapeutic
- đź“° GPCR Weekly News, May 15 to 21, 2023
Hopkins, Exscientia’s founder and CEO was elected a Fellow of the Academy of Medical Sciences Structure Therapeutics
- Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic ...
indicated by the fact that about 40% of all drugs currently used in clinical practice mediate their therapeutic
- GPCR Collaboration: From Models to Medicine
They offer extraordinary therapeutic promise —but their complexity makes them one of the hardest targets
- Drug Discovery Pharmacology Principles That Turn Assays Into Real Medicines
Kenakin highlights that therapeutic efficacy depends on the period during which a drug is actively engaged
- Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors
advancing the understanding of the effects of genetic mutations on GPCR function and provide a proof of therapeutic
- The Hidden Cost of Ambition in Biotech Leadership
A strong preclinical signal opens adjacent therapeutic areas.
- Beyond Clearance: The Strategic Power of Irreversible Drug Binding
When a drug outlives its exposure , toxic interactions can be just as persistent as therapeutic ones.
- Recurrent high-impact mutations at cognate structural positions in class A G protein-coupled ...
cognate positions across GPCR paralogs opens a window into cancer mechanisms and potential approaches to therapeutics
- đź“° GPCR Weekly News - January 2 to 8, 2023
Enter into Multitarget Antibody Discovery Research Collaboration Neurocrine Biosciences and Voyager Therapeutics
- Dr. GPCR University registration is now open! Secure your spot now!
the atomic-level quaternary structure of short-lived GPCR oligomers in live cells Industry News Confo Therapeutics
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! âť„ Dec 2 - 8, 2024
Pharmacology GPCR Jobs GPCR Molecular Pharmacologist Scientist - Biology Scientist I Cell Biology - Tectonic Therapeutic
- Advantages of Fluorescent Probes in GPCR Assays
GPCRs pose a critical challenge in drug discovery: a vast therapeutic potential with many targets yet
- Exploring the Breakthroughs in GPCR Research
GPCRs remain one of the most prolific and fertile therapeutic drug targets.
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
competitive edge: Â Learn to leverage restricted diffusion and rebinding to create drugs with longer therapeutic















